DPIIT recognised startup Government of India
Startup India
Cellogen Therapeutics Private Limited - life sciences in Dadri, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹46.11 Lakh
▲ 306% YoY
Net loss · FY 2025
₹83.74 Lakh
Net margin -181.6%
EBITDA · FY 2025
-₹34.89 Lakh
EBITDA margin -75.7%
Authorised capital
₹16 Lakh
Registered with MCA
Paid-up capital
₹2.64 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Active GSTINs
2
GST registered
About Cellogen Therapeutics Private Limited
Data last updated:
Cellogen Therapeutics Private Limited is a private limited company based in Dadri, Uttar Pradesh, India, recognised as a startup by DPIIT. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 08 June 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U85300UP2021PTC202881. Its GSTIN is 09AAJCC5339A1ZT (Uttar Pradesh). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹16 Lakh and a paid-up capital of ₹2.64 Lakh. It is led by directors Gaurav Kharya and Tanveer Ahmad.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sector 73, Dadri, Uttar Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹46.11 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹83.74 Lakh (net margin -181.6%) and EBITDA of -₹34.89 Lakh (EBITDA margin -75.7%). Revenue has grown at a compounded annual rate (CAGR) of 185% over three years.
The company is associated with 1 brand: Cellogen Therapeutics. The company has 4 deals on record (4 funding rounds), with disclosed funding of ₹38.63 Cr; the latest was in May 2026.
Cellogen Therapeutics Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-07-0002267). For more details, the company can be reached via its website cellogentherapeutics.com.
Company details
CIN U85300UP2021PTC202881
Registration Number 202881
Incorporation Date 08 June 2021
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-DL-07-0002267
CIN history
Cellogen Therapeutics has one previous CIN (Corporate Identification Number): U85300DL2021PTC382053. The current CIN is U85300UP2021PTC202881, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U85300UP2021PTC202881 | Current |
| U85300DL2021PTC382053 | Previous |
Key People
Gaurav Kharya Director Tanveer Ahmad Director Recognitions & Rankings of Cellogen Therapeutics
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-DL-07-0002267
Contact details
Cellogen Therapeutics Private Limited's registered office is in Dadri, Uttar Pradesh. Its website is cellogentherapeutics.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No. 06 9th Floor, Magnus Tower Sector 73, Dadri, Uttar Pradesh, India – 201307
- IndustryLife Sciences, Biotechnology
To see the full contact details of Cellogen Therapeutics Private Limited, buy the company report.
Comprehensive company report
Cellogen Therapeutics Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Cellogen Therapeutics operates one associated brand: Cellogen Therapeutics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| CAR-T cell therapies are developed for cancer and metabolic diseases. | cellogentherapeutics.com |
Financials of Cellogen Therapeutics Private Limited
FY 2025 filings availableCellogen Therapeutics Private Limited reported revenue of ₹46.11 Lakh (up 306% YoY) for FY 2025.
Revenue · FY 2025
₹46.11 Lakh ▲ 306%
Net loss · FY 2025
₹83.74 Lakh margin -181.6%
EBITDA · FY 2025
-₹34.89 Lakh margin -75.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 306%
3 years · compounded
▲ 185%
EBITDA CAGR growth
1 year
▲ 23%
3 years · compounded
▼ 22%
Revenue has grown at a compounded annual rate (CAGR) of 185% over three years, including 306% growth in the latest year. EBITDA rose 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹34.89 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹83.74 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -75.7% | |||
| Net Profit Margin | -181.6% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Cellogen Therapeutics Private Limited, buy the company report.
Board of directors of Cellogen Therapeutics Private Limited
Cellogen Therapeutics has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gaurav Kharya Also directs: Chimera Transplant Solution Private Limited | Director | 08 Jun 2021 | 5 Years 4 Months | Current |
| Tanveer Ahmad | Director | 15 Dec 2023 | 2 Years 10 Months | Current |
Auditor
Cellogen Therapeutics Private Limited is audited by ROHIT SURI & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ROHIT SURI & ASSOCIATES | FY 2023 | 012259N |
Shareholding
The shareholding of Cellogen Therapeutics Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Cellogen Therapeutics Private Limited, buy the company report.
Deals & funding
Cellogen Therapeutics Private Limited has 4 deals on record (4 funding rounds), with disclosed funding of ₹38.63 Cr; the latest was in May 2026.
Total deals
4
Funding rounds
4
Disclosed funding
₹38.63 Cr
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2026 | Funding round | ₹20 Cr | Investors: Kotak Special Situations Fund |
| Jan 2024 | Funding round | ₹16.63 Cr | Investors: Natco Pharma Limited |
| Nov 2022 | Funding round | ₹1.5 Cr | Investors: Alpine Lifescience Private Limited |
| Jul 2022 | Funding round | ₹50 Lakh | Investors: Chimera Transplant Solution Private Limited , an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Cellogen Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cellogen Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Cellogen Therapeutics Private Limited has 1 active EPFO establishment as of Apr 05, 2024.
Active EPFO establishments
1
GST
Cellogen Therapeutics has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAJCC5339A1ZT | Uttar Pradesh | Active | 01 Jan 2024 |
| 07AAJCC5339A1ZX | Delhi | Active | 01 Dec 2021 |
To see the full GST registrations and return filing status of Cellogen Therapeutics Private Limited, buy the company report.
Recent activity
Cellogen Therapeutics Private Limited has 6 board changes on record since 2021: 4 appointments and 2 cessations. The latest: Faisal Nazir Mir ceased to be Director on 15 Dec 2023.
AGM
Cellogen Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Cellogen Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh Ii.
Ceased
Faisal Nazir Mir ceased to be Director.
Ceased
Kullampalayam Vasugamani Shanmugapriya ceased to be Director.
Appointed
Tanveer Ahmad was appointed as Director.
Appointed
Faisal Nazir Mir was appointed as Director.
Appointed
Gaurav Kharya was appointed as Director.
Appointed
Kullampalayam Vasugamani Shanmugapriya was appointed as Director.
Incorporation
08 Jun 2021
Cellogen Therapeutics Private Limited was registered on 08 Jun 2021 with Roc Uttar Pradesh Ii & aged 5 years 4 months as per MCA records.
Frequently asked questions
Cellogen Therapeutics is an active private limited company based in Dadri, Uttar Pradesh, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 08 June 2021 (5+ years old) and is registered under CIN U85300UP2021PTC202881.
Cellogen Therapeutics has 2 current directors:
- Gaurav Kharya - Director
- Tanveer Ahmad - Director
The latest financial statements of Cellogen Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Cellogen Therapeutics is 09AAJCC5339A1ZT, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 07AAJCC5339A1ZX (Delhi).
The CIN (Corporate Identification Number) of Cellogen Therapeutics is U85300UP2021PTC202881. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cellogen Therapeutics was incorporated on 08 June 2021, making it 5+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Cellogen Therapeutics has 4 deals on record (4 funding rounds), with disclosed funding of ₹38.63 Cr; the latest was in May 2026.
Faisal Nazir Mir ceased to be Director on 15 Dec 2023. Kullampalayam Vasugamani Shanmugapriya ceased to be Director on 15 Dec 2023. Tanveer Ahmad was appointed as Director on 15 Dec 2023. Cellogen Therapeutics has 6 board changes on record in total.
Yes, Cellogen Therapeutics is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Cellogen Therapeutics is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-07-0002267).